Trial Profile
The effect of angiotensin receptor blockade alone or in combination with spironolactone on the process of ventricular remodeling in chronic heart failure.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Apr 2012
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil (Primary) ; Spironolactone
- Indications Heart failure
- Focus Pharmacodynamics
- 07 Jan 2010 New trial record